The shares of Symbiotec Pharmalab IPO are commanding a strong premium of ₹270 in the grey market. The GMP of Symbiotec Pharmalab IPO is +270, according to Investorgain.
Market Samachar is a news aggregator. This article was originally published by mint - markets. Tap the button above to read the full story on their site.